Company: AEMD
Filing Date: 2025-06-05
Form Type: 8-K
Source: 0001683168-25-004248
Chunk: 1

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-05
Form: 8-K
Item: Item 8.01
Chunk 1
---
 will be issued one whole share of common stock in exchange for
any fractional interest that such stockholder would have otherwise received as a result of the Reverse Stock Split. The Reverse Stock
Split will affect all stockholders proportionately and will not affect any stockholder’s percentage ownership of the Company’s
common stock, except to the extent that the Reverse Stock Split results in any stockholder owning an additional share.

The Company’s common
stock will begin trading on a split-adjusted basis commencing upon market opening on The Nasdaq Capital Market on June 9, 2025. The new
CUSIP number for the Company’s common stock following the Reverse Stock Split is 00808Y 505.

   2  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  Date: June 5, 2025      Aethlon Medical, Inc.                                                           
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────
                          By:                        /s/ James B. Frakes                                  
                          Name:                      James B. Frakes                                      

   3